Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

RenovoRx (RNXT) Net Income towards Common Stockholders (2025)

Historic Net Income towards Common Stockholders for RenovoRx (RNXT) over the last 1 years, with Q3 2025 value amounting to -$3.1 million.

  • RenovoRx's Net Income towards Common Stockholders changed N/A to -$3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.6 million, marking a year-over-year change of. This contributed to the annual value of -$10.6 million for FY2024, which is N/A changed from last year.
  • Per RenovoRx's latest filing, its Net Income towards Common Stockholders stood at -$3.1 million for Q3 2025.
  • RenovoRx's Net Income towards Common Stockholders' 5-year high stood at -$2.5 million during Q2 2025, with a 5-year trough of -$3.1 million in Q3 2025.